1 / 17

Lenka Fedorkova, Ph.D. Assistant Manager NIH SBIR/STTR Programs

Lenka Fedorkova, Ph.D. Assistant Manager NIH SBIR/STTR Programs. CEO Roundtable : Technical Assistance Programs. National Institutes of Health. Mt. “FDA” ???. NIH Technical Assistance Programs. Niche Assessment Program. Commercialization Assistance Program. Phase I. Phase II.

dante-martinez
Télécharger la présentation

Lenka Fedorkova, Ph.D. Assistant Manager NIH SBIR/STTR Programs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Lenka Fedorkova, Ph.D. Assistant Manager NIH SBIR/STTR Programs CEO Roundtable: Technical Assistance Programs National Institutes of Health

  2. Mt. “FDA” ??? NIH Technical Assistance Programs Niche Assessment Program Commercialization Assistance Program Phase I Phase II Phase III “Valley of Death”

  3. NIH Awardee Needs • Investment = Cash Flow “Valley of Death” • Market Validation = who will buy your product or pay for your service? • Defining Your Customer – Is your technology a “needed” solution to a defined problem? • Penetrating well-established/ crowded markets = Who is your competition versus strategic partner? • Protecting Intellectual Property = your “worth”

  4. Technology Niche Analysis ™ Report helps Phase II submissions: Identify other uses of technology Determines competitive advantages Market size and potential Barriers to entry & strategy Feedback from potential end-users Phase I SBIR/STTR awardees With current or soon to be awarded Phase I (Notice of Award) Niche Assessment Program

  5. Commercialization Assistance Program (CAP) • Personalized Business Mentoring; Knowledge Transfer; Business Outcomes! • Business & strategic planning • Investor & partnership pitch • Technology Value Proposition • FDA regulatory requirements • IP & Licensing Issues • Market Readiness Phase II SBIR/STTR awardees Active or 5 years since completion of project

  6. NIH-CAP PARTICIPANTS: 2004-2013 Biotechnology 116 Companies Other* 142 Companies Diagnostics 97 Companies Pharmaceuticals 89 Companies Healthcare IT 99 Companies Medical Devices 215 Companies *Includes Clinical Research, Instrumentation, Research Tools

  7. How CAP Works • Customized Approach • Commercialization Training Track • Accelerated Commercialization Track • Regulatory Training Track • High-level industry and commercial expertise • Live feedback from active industry contacts • Mediated connections to industry partners and investors • High-quality workshops and events • Nationwide network of resources, referrals

  8. The Impact • How do we measure SUCCESS? • Met with or closed deals with investors • Met with the FDA or obtained approval • Launched a product • Achieved revenue • Signed licensing agreements • Hired new employees • Established partnerships • Signed CDA

  9. NIH-CAP RESULTS: 2004-2012 • Deals: Signed legal documents committing partners to a process, timeframe and outcome, including.: • Acquisitions • Distribution Agreements • Investment • - Licensing Agreements • - Technical Collaborations

  10. Strategic Introductions Acquisitions New Jobs Created Millions Raised WHY NIH-CAP MATTERS! 27 $586+ Results directly attributed by the companies to their participation in CAP 1,680+ 4,400+

  11. Get Connected • NIH Guide for Grants and Contracts (weekly notification) http://grants.nih.gov/grants/guide/listserv.htm • NIH SBIR/STTR Notification • Email LISTSERV@list.nih.gov with ‘subscribe SBIR-STTR your name’ in the message body: • Follow us on Twitter: @NIHsbir • Submit your SBIR/STTR Success Story at our Website: http://nih.sbir.gov

  12. CEO Roundtable

  13. InvivoSciences, Inc. • Provides phenotypic compound screening services for first-in-class drug discovery and drug repositioning • Madison, WI Ayla Annac, MBACo-Founder& CEO • http://www.invivosciences.com/

  14. SenesTech, Inc. • Revolutionary technology for animal pest control that targets the heart of the problem: Reproduction • Flagstaff, AZ • http://senestech.com/ Loretta Mayer, Ph.D. Founder & CEO

  15. Actuated Medical, Inc. • Designs and develops next-generation, FDA-compliant medical devices • Bellefonte, PA Maureen Mulvihill, Ph.D. Co-Founder & CEO • http://www.actuatedmedical.com/

  16. Biopsy Sciences, LLC. • A medical device company best known for their lead products, the BioSEAL and the HydroMARK • Clearwater, FL • http://www.hydromark.com/ John Fisher, M.D. Founder & CEO

  17. Learn More at sbir.nih.gov/tap

More Related